By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Faron Pharmaceuticals Ltd. 

Tykistökatu 6 B, BioCity

Turku    FIN-20520  Finland
Phone: 358-2-469-5151 Fax: 358-2-469-5152



Company News
Faron Pharmaceuticals Ltd. Provides Update At R&D Day 6/14/2016 9:40:17 AM
Faron Pharmaceuticals Ltd. Licenses Traumakine Korean Rights To Pharmbio Korea Inc. (“Pharmbio”) 6/13/2016 9:31:43 AM
Faron Pharmaceuticals Ltd. Expands R&D Strategy For Novel Immunotherapy Drug Candidate, Clevegen 5/26/2016 9:52:32 AM
Faron Pharmaceuticals Ltd. Strengthens Executive Team By Appointing New Medical Director 5/3/2016 8:42:18 AM
Faron Pharmaceuticals Ltd. Files Two New Patents To Strengthen Protection For Novel Immunotherapy Drug Candidate, Clevegen 4/19/2016 10:24:51 AM
Faron Pharmaceuticals Ltd. Annual Results For The Year Ended 31 December 2015 3/10/2016 9:28:20 AM
Faron Pharmaceuticals Ltd. Release: Positive Top-Line Results From The Japanese Phase II Study Of Traumakine For The Treatment Of ARDS 1/7/2016 11:09:31 AM
Faron Pharmaceuticals Ltd. Release: First Patient Recruited In Pan-European Phase III INTEREST Study For Treatment Of Acute Respiratory Distress Syndrome 12/29/2015 8:40:34 AM
Faron Pharmaceuticals Ltd. Awarded €1.5 Million Tekes Funding To Progress Novel Cancer Immunotherapy Clevegen 12/21/2015 12:31:46 PM
Faron Pharmaceuticals Ltd. Release: Admission To AIM And First Day Of Dealings £10 Million Fundraise To Progress Phase III Clinical Trial 11/17/2015 10:51:34 AM